Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chung

Showing results (321-330 of 582) with videos related to

Pageof 59
Sort By:
Obesity (Silver Spring, Md.)|July 20, 2007
Moderate exercise and bright light treatment in overweight and obese individualsAndrea Dunai, Marta Novak, Sharon A Chung, et al.
The New England Journal of Medicine|March 20, 1975
Treatment of gallstones with chenodeoxycholic acid and phenobarbitalM J Coyne, G G Bonorris, A Chung, et al.
Obstetrics and Gynecology|June 1, 2001
Cost-effectiveness of a trial of labor after previous cesareanA Chung, A Macario, Y Y El-Sayed, et al.
Cancer|August 26, 1998
The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimensA A Renshaw, J P Richie, K R Loughlin, et al.
Cancer Research|March 22, 2003
Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccineMaureen A Chung, Yi Luo, Michael O'Donnell, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 25, 2001
Gene therapy for colorectal cancer: therapeutic potentialM J Chen, G A Chung-Faye, P F Searle, et al.
Spine|July 2, 2010
The effect of running exercise on intervertebral disc extracellular matrix production in a rat modelHelena Brisby, Ai Qun Wei, Tim Molloy, et al.
Movement Disorders Clinical Practice|October 27, 2018
Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's DiseaseKathryn A Chung, Brenna M Lobb, Charles F Murchison, et al.
American Journal of Clinical Pathology|May 7, 1999
Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Validation in a cohort of 434 patientsA A Renshaw, J P Richie, K R Loughlin, et al.
The Biochemical Journal|December 15, 1979
Fate of bradykinin-potentiating peptide 9a after intravenous injectionL C Martin, J W Ryan, G H Fisher, et al.
Pageof 59

Showing results (321-330 of 582) with videos related to

Sort By:
Pageof 59
Obesity (Silver Spring, Md.)|July 20, 2007
Moderate exercise and bright light treatment in overweight and obese individualsAndrea Dunai, Marta Novak, Sharon A Chung, et al.
The New England Journal of Medicine|March 20, 1975
Treatment of gallstones with chenodeoxycholic acid and phenobarbitalM J Coyne, G G Bonorris, A Chung, et al.
Obstetrics and Gynecology|June 1, 2001
Cost-effectiveness of a trial of labor after previous cesareanA Chung, A Macario, Y Y El-Sayed, et al.
Cancer|August 26, 1998
The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimensA A Renshaw, J P Richie, K R Loughlin, et al.
Cancer Research|March 22, 2003
Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccineMaureen A Chung, Yi Luo, Michael O'Donnell, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 25, 2001
Gene therapy for colorectal cancer: therapeutic potentialM J Chen, G A Chung-Faye, P F Searle, et al.
Spine|July 2, 2010
The effect of running exercise on intervertebral disc extracellular matrix production in a rat modelHelena Brisby, Ai Qun Wei, Tim Molloy, et al.
Movement Disorders Clinical Practice|October 27, 2018
Assessment of an Objective Method of Dyskinesia Measurement in Parkinson's DiseaseKathryn A Chung, Brenna M Lobb, Charles F Murchison, et al.
American Journal of Clinical Pathology|May 7, 1999
Maximum diameter of prostatic carcinoma is a simple, inexpensive, and independent predictor of prostate-specific antigen failure in radical prostatectomy specimens. Validation in a cohort of 434 patientsA A Renshaw, J P Richie, K R Loughlin, et al.
The Biochemical Journal|December 15, 1979
Fate of bradykinin-potentiating peptide 9a after intravenous injectionL C Martin, J W Ryan, G H Fisher, et al.
Pageof 59